CORDIS
EU research results

CORDIS

English EN
Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics

Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics

Objective

VHFMoDRAD will develop and deliver rapid and point-of-care singel/multiplex diagnostic tool(s) that will significantly increase our capacity to handle outbreaks with Filoviruses and other viral hemorrhagic fever diseases in Africa. The overall aim of VHFMoDRAD is to carry on the outcome of the currently running EbolaMoDRAD project to the next level, which is behind of the scope of that project.
The goals of VHFMoDRAD will be done via a multidisciplinary research consortium drawn from key European and African research organisations and also industry and SMEs, thus consolidating previous tools and knowledge. VHFMoDRAD will also put in place a strong capacity building programme in West Africa The project will disseminate widely all results as they become available, notably to public health bodies and non-governmental organisations (NGOs), via a strong outreach programme.
To achieve this overall aim an intensive work plan will be put in place, with the following specific objectives:
- to develop rapid molecular and serological single/multiplex detection methods;
- perform preclinical validation of diagnostic tools;
- to validate the successful diagnosis tools under field conditions;
- implement a strong capacity building programme in West Africa by a twining program;
- to exploit results;
- to disseminate the results to public health bodies, NGOs, outbreak management teams and local hospitals in West Africa.

Coordinator

FOLKHALSOMYNDIGHETEN

Address

Nobels Vag 18
171 82 Solna

Sweden

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 446 250

Participants (12)

Sort alphabetically

Sort by EU Contribution

Expand all

INSERM TRANSFERT SA

France

EU Contribution

€ 215 250

THE UNIVERSITY OF STIRLING

United Kingdom

EU Contribution

€ 334 905

Department of Health

United Kingdom

EU Contribution

€ 202 286,25

CORIS BIOCONCEPT SPRL

Belgium

EU Contribution

€ 320 000

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 477 062,50

KOBENHAVNS UNIVERSITET

Denmark

EU Contribution

€ 145 133,75

ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

Italy

EU Contribution

€ 200 000

INSTITUT PASTEUR DE DAKAR

Senegal

EU Contribution

€ 146 250

RD-BIOTECH

France

EU Contribution

€ 267 000

CEPHEID EUROPE

France

UNIVERSITE D'AIX MARSEILLE

France

EU Contribution

€ 496 875

EMERGENCY LIFE SUPPORT FOR CIVILIAN WAR VICTIMS ONG ONLUS

Italy

EU Contribution

€ 65 000

Project information

Grant agreement ID: 823666

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2022

Funded under:

H2020-EU.3.1.

  • Overall budget:

    € 5 050 012,50

  • EU contribution

    € 3 316 012,50

Coordinated by:

FOLKHALSOMYNDIGHETEN

Sweden